A cost-effectiveness analysis of eletriptan 40 and 80 mg versus sumatriptan 50 and 100 mg in the acute treatment of migraine

N. Wells, J. Hettiarachchi, M. Drummond, D. Carter, T. Parpia, F. Pang

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)438-447
Number of pages10
JournalValue in Health
Issue number4
Publication statusPublished - 2003

Cite this